Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Pakistan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Pakistan Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20101
20113
20171
20181
20196
20203
20217
20225
20236
20245
202511
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Riphah International University13
Dow University of Health Sciences4
Getz Pharma4
Novo Nordisk A/S4
Bahria University2
GlaxoSmithKline2
Khyber Medical University Peshawar2
Lahore General Hospital2
SINA Health Education and Welfare Trust2
University of Veterinary and Animal Sciences, Lahore - Pakistan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 254
Diabetes Mellitus6
Diabetic Nephropathies4
Diabetic Neuropathies4
Hyperglycemia4
Insulin Resistance2
Obesity2
Renal Insufficiency, Chronic2
Albuminuria1
Binge-Eating Disorder1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.